Elsevier pledges AI tools and €1m annual support to European research initiative

Elsevier has pledged 4,000 complimentary licences for its AI-powered research and clinical tools, alongside an estimated €1m a year in funding and in-kind support, as part of the European Commission’s AI in Science Enablers Initiative.
The commitment, due to be announced at the AI in Science Summit in Dublin, is intended to support AI adoption across European research and healthcare, strengthen research collaborations and develop the next generation of AI specialists.
The summit brings together more than 1,000 representatives from research, technology, business and policy to launch the Commission’s initiative, which aims to mobilise private-sector and philanthropic support for European science.
As part of its pledge, Elsevier will provide 1,000 complimentary licences for each of four products: LeapSpace, ClinicalKey AI, ClinicalKey Nursing AI and Complete Anatomy.
LeapSpace, Elsevier’s AI-powered research workspace, is designed to support researchers with complex tasks across the research workflow. The company also plans to develop a Europe-wide challenge in collaboration with the European Commission.
ClinicalKey AI provides evidence-based clinical decision support, while ClinicalKey Nursing AI is designed to assist nurses with clinical decision-making and professional development. Complete Anatomy is a 3D anatomy education platform.
Beyond access to its technology, Elsevier has committed an estimated €1m annually in funding and in-kind support to advance AI research and training across Europe.
The programme will include at least three new collaborations each year with European research institutions, providing access to Elsevier’s content and knowledge discovery tools, as well as expertise in data science, ethics and software development.
Elsevier will also participate in the Horizon-funded AIRIS project, which supports AI-enabled hypothesis generation in biomedicine, and establish a new Centre on Hybrid Intelligence for Trustworthy Research in partnership with the University of Amsterdam and Vrije Universiteit Amsterdam.
The company additionally plans to provide training and career development opportunities for approximately 10 PhD candidates, postdoctoral researchers and master’s students each year through its internal programmes.
Kumsal Bayazit, CEO of Elsevier, said: “Europe’s world-leading researchers and clinicians are working at the frontier of AI, and they need platforms and partnerships they can trust.
“Through this pledge, Elsevier is bringing the full breadth of its capabilities to that effort – funded collaborations, training for the next generation of scientists, and research-grade AI and clinical solutions for better outcomes. We’re proud to support the European Commission’s AI in Science Enablers Initiative and to help build an AI research ecosystem for Europe that is innovative, responsible, and sustainable.”
